Possible SARS‑CoV‑2 and Mycoplasma pneumoniae co‑detection during the early COVID‑19 pandemic: diagnostic challenges in a resource‑limited setting
Access Microbiology · 01.11.2026 · 8 (11)
DOI: 10.1099/acmi.0.001285.v3 ↗Kurz gefasst
Fallbericht in der Zeitschrift Access Microbiology, erschienen am 01.11.2026. Verfasst von Hidehiro Watanabe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control and Prevention/Department of Infectious Diseases, Tokyo Medical University Hospital, Tokyo, Japan. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
During the early Coronavirus disease 2019 (COVID-19) pandemic, diagnostic pathways were disrupted by limited access to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing, evolving clinical knowledge and substantial diagnostic uncertainty. We report a case in which Mycoplasma pneumoniae ( M. pneumoniae ) and SARS-CoV-2 were both detected early in the clinical course of a previously healthy 35-year-old man in April 2020. The patient met all six Japanese clinical criteria for atypical pneumonia, and chest computed tomography demonstrated multifocal ground-glass opacities compatible with atypical pneumonia. Clarithromycin was initiated on Day 4. An M. pneumoniae particle agglutination titre of 1 : 640 was recognized on Day 6, supporting possible M. pneumoniae infection, although serology alone cannot confirm acute disease. Later that afternoon, a positive SARS-CoV-2 PCR result was reported, prompting reframing of the working diagnosis towards COVID-19. Antimicrobial therapy was temporarily discontinued and subsequently adjusted. This case illustrates how early-pandemic diagnostic constraints, delayed availability of microbiological results and overlapping radiological findings created diagnostic complexity. Although cognitive biases such as anchoring may have contributed to the diagnostic shift, available information is insufficient to establish them as definitive causes. Instead, this case highlights the challenges of interpreting limited diagnostic data in a resource-restricted setting. As contemporary COVID-19 disease severity has attenuated and atypical bacterial infections have resurged, maintaining awareness of possible co-detection remains important for accurate clinical assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infection Control and Prevention/Department of Infectious Diseases, Tokyo Medical University Hospital, Tokyo, Japan.
- Department of Infection Control and Prevention/Department of Infectious Diseases, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.
ORCID-Profile: Hidehiro Watanabe, Hiroaki Fujita, Yusuke Watanabe, Itaru Nakamura
Zitieren
APA
Watanabe, H., Kobayashi, T., Takebayashi, Y., Takahashi, H., Fujita, H., Watanabe, Y., & Nakamura, I. (2026). Possible SARS‑CoV‑2 and Mycoplasma pneumoniae co‑detection during the early COVID‑19 pandemic: diagnostic challenges in a resource‑limited setting. Access Microbiology, 8(11). https://doi.org/10.1099/acmi.0.001285.v3
Vancouver
Watanabe H, Kobayashi T, Takebayashi Y, Takahashi H, Fujita H, Watanabe Y, et al. Possible SARS‑CoV‑2 and Mycoplasma pneumoniae co‑detection during the early COVID‑19 pandemic: diagnostic challenges in a resource‑limited setting. Access Microbiology. 2026;8(11). doi:10.1099/acmi.0.001285.v3
BibTeX
@article{Watanabe2026,
author = {Watanabe, Hidehiro and Kobayashi, Takehito and Takebayashi, Yasuyuki and Takahashi, Hideaki and Fujita, Hiroaki and Watanabe, Yusuke and Nakamura, Itaru},
title = {Possible SARS‑CoV‑2 and Mycoplasma pneumoniae co‑detection during the early COVID‑19 pandemic: diagnostic challenges in a resource‑limited setting},
journal = {Access Microbiology},
year = {2026},
volume = {8},
number = {11},
doi = {10.1099/acmi.0.001285.v3}
}
EUVIMED